DexCom, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 5 | $0.27 | $0.27 | $0.27 |
| Q2 2024 | 5 | $0.39 | $0.39 | $0.39 |
| Q3 2024 | 6 | $0.43 | $0.43 | $0.43 |
| Q4 2024 | 15 | $0.48 | $0.56 | $0.52 |
| Q1 2025 | 9 | $0.32 | $0.47 | $0.39 |
| Q2 2025 | 8 | $0.47 | $0.50 | $0.48 |
| Q3 2025 | 4 | $0.52 | $0.56 | $0.54 |
| Q4 2025 | 5 | $0.60 | $0.64 | $0.62 |
| Q1 2026 | 5 | $0.45 | $0.48 | $0.46 |
| Q2 2026 | 3 | $0.56 | $0.60 | $0.58 |
| Q3 2026 | 3 | $0.63 | $0.68 | $0.65 |
| Q4 2026 | 5 | $0.73 | $0.78 | $0.76 |
DexCom, Inc. Earnings Date And Information
DexCom, Inc. last posted its earnings results on Thursday, October 24th, 2024. The company reported $0.45 earnings per share for the quarter, topping analysts' consensus estimates of $0.4348 by $0.0152. The company had revenue of 994.20 M for the quarter and had revenue of 3.62 B for the year. DexCom, Inc. has generated $1 earnings per share over the last year ($1.3 diluted earnings per share) and currently has a price-to-earnings ratio of 42.17. DexCom, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based on prior year's report dates.
DexCom, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/24/2024 | Q3 2024 | $0.43 | $0.35 | -0.08 | $990.44 M | $994.20 M |
| 07/25/2024 | Q2 2024 | $0.39 | $0.36 | -0.03 | $1.04 B | $1.00 B |
| 04/25/2024 | Q1 2024 | $0.27 | $0.38 | 0.11 | $921.00 M | |
| 02/08/2024 | Q4 2023 | $0.43 | $0.67 | 0.24 | $1.03 B | |
| 10/26/2023 | Q3 2023 | $0.34 | $0.31 | -0.03 | $939.64 M | $975.00 M |
| 07/27/2023 | Q2 2023 | $0.23 | $0.30 | 0.07 | $841.16 M | $871.30 M |
| 04/27/2023 | Q1 2023 | $0.15 | $0.13 | -0.02 | $741.50 M | |
| 02/09/2023 | Q4 2022 | $0.26 | $0.24 | -0.02 | $815.20 M | |
| 10/27/2022 | Q3 2022 | $0.24 | $0.24 | 0 | $751.80 M | $769.60 M |
| 07/28/2022 | Q2 2022 | $0.17 | $0.12 | -0.05 | $697.50 M | $696.20 M |
| 04/28/2022 | Q1 2022 | $0.13 | $0.23 | 0.1 | $628.80 M | |
| 02/14/2022 | Q4 2021 | -$0.05 | $698.20 M | |||
| 10/28/2021 | Q3 2021 | $0.16 | $0.23 | 0.07 | $618.65 M | $650.20 M |
| 07/29/2021 | Q2 2021 | $0.11 | $0.20 | 0.09 | $551.67 M | $595.10 M |
| 04/29/2021 | Q1 2021 | $0.08 | $0.15 | 0.07 | $505.00 M | |
| 02/11/2021 | Q4 2020 | $0.23 | $0.23 | 0 | $568.90 M | |
| 10/27/2020 | Q3 2020 | $0.16 | $0.19 | 0.03 | $500.90 M | $500.90 M |
| 07/28/2020 | Q2 2020 | $0.08 | $0.12 | 0.04 | $416.62 M | $451.80 M |
| 04/28/2020 | Q1 2020 | $0.04 | $0.06 | 0.02 | $405.10 M | |
| 02/13/2020 | Q4 2019 | $0.18 | $0.25 | 0.07 | $462.80 M |
DexCom, Inc. Earnings: Frequently Asked Questions
-
When is DexCom, Inc.'s earnings date?
DexCom, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates.
-
Did DexCom, Inc. beat their earnings estimates last quarter?
In the previous quarter, DexCom, Inc. (:DXCM) reported $0.45 earnings per share (EPS) to beat the analysts' consensus estimate of $0.4348 by $0.0152.
-
How can I listen to DexCom, Inc.'s earnings conference call?
The conference call for DexCom, Inc.'s latest earnings report can be listened to online.
-
How can I read DexCom, Inc.'s conference call transcript?
The conference call transcript for DexCom, Inc.'s latest earnings report can be read online.
-
How much revenue does DexCom, Inc. generate each year?
DexCom, Inc. (:DXCM) has a recorded annual revenue of $3.62 B.
-
How much profit does DexCom, Inc. generate each year?
DexCom, Inc. (:DXCM) has a recorded net income of $3.62 B. DexCom, Inc. has generated $1.44 earnings per share over the last four quarters.
-
What is DexCom, Inc.'s price-to-earnings ratio?
DexCom, Inc. (:DXCM) has a price-to-earnings ratio of 42.17 and price/earnings-to-growth ratio is 24.18.
